Literature DB >> 8028656

Tumour-suppressor genes. X-rays strike p53 again.

B Vogelstein, K W Kinzler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8028656     DOI： 10.1038/370174a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  p53's believe it or not: lessons on transcription-independent death.

Authors:  Jerry E Chipuk; Douglas R Green
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

2.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  The inhibitory action of long-chain fatty acids on the DNA binding activity of p53.

Authors:  Hiroshi Iijima; Nobuyuki Kasai; Hiroyuki Chiku; Shizuka Murakami; Fumio Sugawara; Kengo Sakaguchi; Hiromi Yoshida; Yoshiyuki Mizushina
Journal:  Lipids       Date:  2006-06       Impact factor: 1.880

Review 4.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Friend leukemia virus infection enhances DNA damage-induced apoptosis of hematopoietic cells, causing lethal anemia in C3H hosts.

Authors:  Masanobu Kitagawa; Shuichi Yamaguchi; Maki Hasegawa; Kaoru Tanaka; Toshihiko Sado; Katsuiku Hirokawa; Shiro Aizawa
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Crosstalk between transcription factors and microRNAs in human protein interaction network.

Authors:  Chen-Ching Lin; Ya-Jen Chen; Cho-Yi Chen; Yen-Jen Oyang; Hsueh-Fen Juan; Hsuan-Cheng Huang
Journal:  BMC Syst Biol       Date:  2012-03-13

7.  A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.

Authors:  G Pratesi; P Perego; D Polizzi; S C Righetti; R Supino; C Caserini; C Manzotti; F C Giuliani; G Pezzoni; S Tognella; S Spinelli; N Farrell; F Zunino
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

8.  Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.

Authors:  B Smith-Sørensen; J Kaern; R Holm; A Dørum; C Tropé; A L Børresen-Dale
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.